A Nonionic Inhibitor with High Specificity for the UDP-Gal Donor Binding Site of Human Blood Group B Galactosyltransferase: Design, Synthesis, and Characterization
- 28 February 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (5) , 2150-2154
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Significant association between ABO blood group and pancreatic cancerWorld Journal of Gastroenterology, 2010
- Synthesis of Glycosyltransferase InhibitorsSynthesis, 2009
- ABO Blood Group and the Risk of Pancreatic CancerJNCI: Journal of the National Cancer Institute, 2009
- Bisubstrate Analogues as Glycosyltransferase InhibitorsCurrent Topics in Medicinal Chemistry, 2009
- Glycosyltransferases: Structures, Functions, and MechanismsAnnual Review of Biochemistry, 2008
- ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational ChangesJournal of Biological Chemistry, 2008
- Blood Group B Galactosyltransferase: Insights into Substrate Binding from NMR ExperimentsJournal of the American Chemical Society, 2006
- The structural basis for specificity in human ABO(H) blood group biosynthesisNature Structural & Molecular Biology, 2002
- Carbohydrate mimetics-based glycosyltransferase inhibitorsBioorganic & Medicinal Chemistry, 2001
- Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancerBiochimica et Biophysica Acta (BBA) - General Subjects, 1999